United Therapeutics Corp vs Abbvie Inc.
UTHR vs ABBV — side-by-side comparison from reported financials. UTHR leads 8, ABBV leads 3 of 11 comparable metrics.
United Therapeutics Corp
UTHR · Healthcare
$549.16+3.07%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | UTHR | ABBV |
|---|---|---|
| Price | $549.16 | $276.43 |
| Market cap | $23.6B | $488B |
| Revenue (TTM) | $3.15B | $64.4B |
| Revenue growth | +18.0% | +1.8% |
| Net margin | 41.6% | 9.8% |
| Free cash flow | $1.09B | $18.2B |
| Net cash (debt) | $2.88B | ($56.2B) |
| 1-year price return | +23.3% | +19.8% |
| P/E | 18.0 | 77.4 |
| P/E vs own history (cheap-side %) | 26% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 20% | 96% |
| Altman Z-score | 21.46 | 2.33 |
| CV checks passed | 10 of 10 | 9 of 10 |
| Employees | 1,400 | 57,000 |
Full résumé-style profiles: UTHR CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.